Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cinnora versus methotrexate for prednisolone-resistant idiopathic granulomatous mastitis
IRCT20211018052807N1Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Nov 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Granulomatous lobular mastitis (GLM) comparing Cinnora with Methotrexate (2 arms). Primary endpoint: Treatment response based on reduction in breast mass size and inflammation. Started Nov 2021; status: completed.
02
Drugs
CinnoRAmethotrexate
03
Conditions
Granulomatous lobular mastitis (GLM)
Beyond the preview
Go deeper on IRCT20211018052807N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211018052807N1.